Stable CIDP, Twelve Weeks of Training, Zero Flares

Diane is 55. Multiple sclerosis diagnosed at 41, three orthopedic surgeries since, intermittent fasting by necessity not trend because the morning steroid cycle decides whether breakfast is a good idea. The MS gets the headlines. The chronic inflammatory demyelinating polyneuropathy diagnosed in 2023 has been the quieter file in the chart.

By the second hour of her once-a-week pool walk she is moving slower than the retirees in the lane next to her. Her neurologist wrote "stay active" on the discharge summary and handed her a pamphlet that recommends walking. She has been walking for a year. The EMG numbers got worse anyway.

She comes in asking the question every CIDP patient eventually asks. Will training help, or will it land me back in the lab.

For a long time the honest coaching answer was a shrug. That answer is no longer defensible.

Start with what is actually broken

A peripheral nerve is a cable. Schwann cells wrap each axon in lipid-rich myelin. That insulation is what makes signals jump node-to-node fast enough for grip to feel precise.

CIDP is the immune system deciding the insulation is foreign. Macrophages chew the paranodal region. In some cases autoantibodies hit neurofascin-155, contactin-1, or CASPR1, and the axo-glial junction breaks down.

Conduction slows. Diane's mid-pool legs start filing for divorce. The question is not "is exercise good." The question is what training does to that exact failure mode.

Five mechanisms, none speculative

The cellular machinery for nerve repair responds to load. That is the through-line.

Aerobic exercise upregulates BDNF, GDNF, and NGF — the three growth factors Schwann cells need to do repair work. In rodent demyelination models, treadmill training accelerates remyelination versus sedentary controls.

Progressive resistance forces motor unit recruitment per the Henneman size principle. In partially denervated muscle, surviving neurons sprout collateral axons to reinnervate orphaned fibers. You are not regenerating the failed axon. You are training every one that still works.

Cycling drives PGC-1 alpha, the master switch for mitochondrial biogenesis. More mitochondria per surviving fiber means more usable torque per motor unit. That is why VO2peak climbs in CIDP cohorts even when nerve conduction velocity does not.

Acute exercise spikes IL-6 from contracting muscle, which acts as a systemic anti-inflammatory and suppresses TNF-alpha. Chronic training shifts the regulatory T-cell to effector T-cell ratio. In an autoimmune demyelinating disease, that is noise reduction at the level of the process driving the disease.

Aerobic conditioning also improves capillary density in the vasa nervorum. Better perfusion means faster clearance of inflammatory debris and better substrate to the Schwann cells doing the repair.

What Markvardsen 2018 actually showed

A supervised 12-week protocol got double-digit gains in both domains with zero disease destabilization.

The Copenhagen team ran two linked interventions in stable CIDP patients on maintenance IVIG.

The aerobic arm sat on a cycle ergometer, three sessions a week, progressing toward 70 to 80 percent of VO2peak. VO2peak rose 11 to 17 percent depending on the expression. Lactate threshold workload climbed in parallel.

The resistance arm ran progressive isokinetic and isotonic work, three sessions a week, knee extensors and flexors and elbow flexors. Isokinetic knee extensor peak torque rose roughly 14 percent on the trained side. Fatigue Severity Scale scores dropped meaningfully.

The safety readout was the part that closed the debate. Zero participants crossed the deterioration threshold on the Overall Neuropathy Limitations Scale, the MRC sum score, or the nerve conduction panel. No training-attributable flares.

That is not a cautious "might help." That is a hard number with a hard safety ceiling.

Why "rest" is the wrong default

The traditional caution came from post-polio overwork-weakness theory and a handful of case reports. That extrapolation does not survive contact with CIDP data.

In stable disease, detraining is the faster road to decline.

A sedentary CIDP patient loses cardiorespiratory capacity on top of the neural deficit. Fatigue compounds. Falls risk compounds. The neurological disease is immunological. The deconditioning is trainer-addressable. Conflating them is a programming error.

This is the pattern Chiron, the AI head coach inside LIM, flags in the daily program review. When a CIDP client logs three consecutive sub-target walking days, the system pings before the strength numbers regress, not after.

Program around the infusion cycle, not the calendar week

Heavy load goes in the post-infusion peak window. The wear-off week gets zone 2 and technique.

Maintenance IVIG patients live in a predictable arc. Days 1 to 3 post-infusion can include headache and flu-like residue. Days 4 to 14 are the functional peak. The final 3 to 7 days before the next infusion are the wear-off window with returning weakness, documented in the strength-fluctuation literature on stable CIDP.

Heavy loading belongs in the peak window. The wear-off window takes low-intensity work and technique practice. Not PR attempts.

For Diane on the MS-plus-CIDP file, that means two in-peak-window sessions on the days her morning steroid window is stable, and one active-recovery ride on the day after. Recumbent cycle over treadmill, because the fall-risk math on an ataxic patient with three orthopedic surgeries in the file is not a debate.

This is what HERMES is built for. The research engine pulls 12,000 fitness and rehab papers a week, so the protocol updates the moment new evidence on demyelinating disease and exercise lands. The calendar bends to the cycle, not the other way around.

Resistance load and autonomic load

Neuropathy patients are routinely under-loaded because trainers confuse sensory ataxia with fragility.

The Markvardsen protocol used 70 to 80 percent of 1RM, three sets, supervised, progressing every two weeks. That is not a gentle protocol.

Knee extension, leg press, hip hinge, seated row, chest press, and a loaded carry that doubles as autonomic stress. Balance work goes at the end of the session. Proprioceptive training under fatigue is where falls get rehearsed.

Cap at two resistance sessions per week on flare-risk weeks. Three on stable weeks. The daily AI program update worker rewrites the week the moment Diane's HealthKit logs a poor overnight, so a missed REM block does not quietly turn Tuesday's leg press into a face-plant.

Small-fiber autonomic involvement is common in CIDP. Orthostatic intolerance, thermoregulation issues, sleep fragmentation. The MS file amplifies every piece of that.

Myelin is lipid. Remyelination needs substrate. Alongside the neurologist's plan:

• Methylcobalamin 1,000 mcg sublingual, not cyanocobalamin
• Methylfolate 400 to 800 mcg, not folic acid, to dodge the unmetabolized-folic-acid problem in MTHFR variants
• D3 5,000 IU with K2 MK-7 100 mcg for regulatory T-cell function
• Magnesium glycinate 400 mg at night for sleep consolidation and cramp reduction
• Alpha-lipoic acid 600 mg, with reasonable mechanistic carryover from the diabetic neuropathy literature

Hydration and sodium get programmed, not suggested. A post-infusion day in dry hospital HVAC can pull two to three liters before anyone notices.

Monitoring and red flags

Every four weeks: timed 10-meter walk, 30-second sit-to-stand, grip dynamometry, Fatigue Severity Scale.

Two consecutive sessions of regression is a call-the-neurologist signal. Not a push-harder signal. Subjective weakness outpacing the DOMS window pauses training. So does new sensory level, bowel or bladder change, or cranial nerve involvement. None of those are training-induced in stable CIDP. The coach's job is to notice them first.

What twelve weeks actually buys

A well-programmed replication of the Markvardsen protocol in a stable CIDP client buys a 50 to 70 meter gain on the six-minute walk, a sit-to-stand jump from the low double digits to the high teens, grip that holds steady in a progressive disease, and a morning where Diane finishes her pool block without the mid-set sit-down.

That is the ceiling of what rehab offers in a demyelinating disease. It is not nothing.

Putting it in practice

Jake, the founder, is a hospital security supervisor who lost 112 pounds on the same autonomic-first, schedule-aware framework — minus the immunology. The neuropathy population needs that framework more, not less.

The infusion schedule is a constraint, not a contraindication. "Stay active" without a protocol is the same as no advice at all.

If you are a CIDP patient, a neurologist sending one, or a trainer who got handed one and went pale, start here.

---

The data behind this

• Markvardsen LH et al. *Neurology.* 2018 — two linked 12-week interventions in stable CIDP patients on maintenance IVIG. Aerobic arm: cycle ergometer, 3 sessions/week, progressing toward 70-80% VO2peak; VO2peak rose 11-17%. Resistance arm: progressive isokinetic and isotonic at 70-80% 1RM; knee extensor peak torque rose ~14% on the trained side. Zero deteriorations on ONLS, MRC sum, or NCS panel.
• Bobinski F et al. *Neuroscience.* 2018 — treadmill training accelerated remyelination versus sedentary controls in rodent demyelination models.
• Pedersen BK. *Physiological Reviews.* 2020 — IL-6 from contracting muscle as systemic anti-inflammatory with TNF-alpha suppression.
• Hughes RA et al. *Brain.* 2008 — strength fluctuations across the IVIG cycle in stable CIDP.
• Ziegler D et al. *Diabetes Care.* 2006 — alpha-lipoic acid 600 mg in diabetic neuropathy with NNT ~6 and reasonable mechanistic carryover.
• 2021 systematic review on exercise in CIDP — *Journal of the Peripheral Nervous System*; pooled evidence consistent with Markvardsen safety and efficacy signal.
• BDNF/GDNF/NGF Schwann-cell substrate literature and PGC-1 alpha mitochondrial-biogenesis pathway are standard background in exercise neurobiology; cited collectively here rather than per-paper.
• Diane's six-minute walk and sit-to-stand numbers are illustrative of the composite MS-plus-CIDP persona; individual outcomes vary with disease activity and infusion cadence.
• Jake's own numbers: 308 → 196 on 12-hour overnight hospital security shifts. Sample of one — informed perspective on the autonomic-first framework, not a replication of the Markvardsen protocol.